RE:Proper Research on MedXThe report is pretty much what you have reported in the past. A few takeaways.
the report has a target price of .45. Which would be great and I think long term we will get there. The lack of a follow up in the Netherlands with respect to the couple more machines by last years end would have indicated a really good forward momentum. ???What happened with that?
a quote from the report and I am only guessing from a speculative buy is driven by the enormous amount dilution is this
Potential 12-month return is high (>15%) but given elevated risk, investment could result in a material loss
Care to comment on the above follow up from Netherlands deal and the quote?